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Summary. Quantitative and cell-type-specific 
expression of c-fos and c-jun genes after 17B-estradiol 
(E2) stimulation, was investigated in the uteri of 
neonatally diethylstilbestrol (DES)-exposed and 
ovariectomized adult mice (neoDES-mice), employing 
Northern blot analysis, immunohistochemistry and in 
situ hybridization. The c-fos mRNA level before E2 
injection (at baseline) was about 2.2-fold higher in 
neoDES-mice than in vehicle-treated control mice. In 
controls, E2 treatment transiently increased c-fos mRNA 
levels, showing a peak value (15.8-fold relative to the 
baseline) after 2 hours. In neoDES-mice, c-fos mRNA 
level reached a peak showing a 2.1-fold increase 
compared with its baseline value 1 hour after E2 
injection. Immunohistochemistry and in s i tu  
hybridization revealed that c-fos protein (Fos) and 
mRNA are induced in the epithelium and vascular 
endothelium in both groups. Most uterine epithelia of 
neoDES-mice revealed low sensitivity to the c-fos 
expression after E2 administration compared with those 
of vehicle-treated controls, whereas few epithelia 
showed high c-fos mRNA expression even at baseline. 
The c-jun mRNA concentration in the neoDES-mice 
uteri at baseline was 70% of that in vehicle-treated 
controls. At 1 hour after E2 injection, c-jun mRNA 
levels increased 1.8-fold in controls and 1.3-fold in the 
neoDES-mice relative to each baseline value. There were 
no significant differences in the distribution pattern of c- 
jun protein (Jun) and mRNA in the uteri of either 
groups; E2 stimulated c-jun mRNA expression in the 
stromal and myometrial cells but suppressed it in the 
epithelial cells, whereas intensity of c-jun immuno- 
staining increased in the three cell types. The permanent 
changes in the expression of estrogen-regulated 
protooncogenes, c-fos and c-jun genes, by neonatal DES 
exposure may be responsible for the wide range of 
abnormalities in the genital tract of mature animals. 
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lntroduction 
It is well known that estrogen administration to 
prenatal or neonatal animals elicits a wide range of 
irreversible abnormalities including carcinogenesis in the 
reproductive organs (Forsberg, 1969; Bern et al., 1975; 
McLachlan et al., 1975). Takasugi (1963) demonstrated 
that ovary-independent proliferation and cornification of 
vagina1 epithelium developed in adult mice exposed 
perinatally to 17B-estradiol (E2). Newbold et al. (1990) 
reported that uterine adenocarcinoma in mice exposed 
neonatally to artificial estrogen, diethylstilbestrol (DES), 
for 5 days occurred in a time- and dose-related manner, 
and that these DES-induced uterine tumors depended on 
postpubertally secreted estrogen. 
Estrogen st imulates  cell  proliferation and 
differentiation in the female reproductive organs. 
Hormone-occupied estrogen receptors (ERs) bind to the 
estrogen responsive elements of target genes and 
modulate the transcription of these genes (Klein-Hitpass 
et al., 1986; Kumar and Chambon, 1988; Lannigan and 
Notidis, 1989). ERs also mediate gene transcription from 
an AP-1 enhancer element that requires ligand and AP-1 
transcription factors, dimer of Fos and Jun family 
proteins, for the transcriptional activation (Gaub et al., 
1990; Umayahara et al., 1994; Paech et al., 1997). These 
two regulatory pathways are thought to be interactive 
through a signal transducing pathway which is mediated 
by cell membrane with growth factors such as epidermal 
growth factor (EGF) and insulin-like growth factor (van 
der Burg et al., 1990; Katzenellenbogen, 1996). 
The expression pattern of Fos and Jun, major 
components  of AP-1 complexes, might play an 
important role in epithelial proliferation, not only in the 
uteri of normal mice but also in neonatally estrogen- 
exposed mice, and might participate in the development 
of various abnormalities in the uteri of neonatally DES- 
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exposed mice (Persico et al., 1990; Kirkland et al., 1992; 
Webb et al., 1993; Kamiya et al., 1996; Yamashita et al., 
1996). Recent studies have demonstrated that both c-fos 
and c-jun protooncogene expression was under direct 
control of estrogen (hose-Mitchell et al., 1988; Weisz 
and Bresciani, 1988). In the uteri of ovariectomized 
rodents, estrogen transiently activated c-fos expression in 
the epithelial cells, and stimulated c-jun expression in 
stromal and myometrial cells but suppressed c-jun 
expression in epithelial cells (Bigsby and Li, 1994; 
Nephew et al., 1994; Yamashita et al., 1996). 
However, a few studies have been carried out to 
demonstrate the expression of c-fos and c-jun 
protooncogenes in the reproductive organs of perinatally 
estrogenized animals. Kamiya et al. (1996), using 
Northern blot analysis, reported that expression of c-fos 
and c-jun mRNAs was greater (6- and 3-fold) in the uteri 
of neonatally DES-exposed 50-day-old ovariectomized 
mice. They also showed that both c-fos and c-jun mRNA 
expression were stimulated transiently in the uteri of 
DES-unexposed control mice after single estrogen 
injection, whereas c-fos and c-jun expression were not 
changed in the uteri of neonatally DES-exposed mice. 
By employing immunohistochemistry, Falck and 
Forsberg (1996) showed that Fos was more highly 
expressed in the uterine epithelium and stromal cells of 
8-week-old mice which were treated with DES 
neonatally and ovariectomized at the age of 6 weeks, 
than in those cells of controls. 
In this study, we tried to verify the quantitative and 
cell-type-specific expression of c-fos and c-jun 
protooncogenes, and to analyze the temporal changes of 
expression of these genes in the uteri of neonatally DES- 
treated or untreated 12-week-old mice which were 
ovariectomized at the age of 10  weeks by employing 
Northern blot analysis, immunohistochemistry and in 
situ hybridization. 
Materials and methods 
Animals and tissue collection 
Pregnant CD-1 mice were obtained from Clea Japan 
Inc. (Tokyo, Japan). Mice were housed at 21 to 22 "C 
with a 12-hour alternating light-dark cycle at Keio 
University Animal Facility (Tokyo, Japan). Neonatal 
mice were given subcutaneous injections of 4 pg of DES 
(Sigma Chemical Co., St. Louis, MO) dissolved in 0.02 
m1 sesame oil (neoDES-mice) or vehicle alone for 5 
days, starting within 24 hours after birth. The female 
mice were ovariectomized at the age of 10 weeks. At 2 
weeks after ovariectomy, the animals received an intra- 
peritoneal injection of 0.1 m1 of 17B-estradiol (E2, 20 
pg/kg  bw; Sigma) and were killed a t  O (without 
treatment, baseline), 1, 2, and 3 hours after the injection. 
For immunohistochemical analysis, small pieces of 
uterine horn were mounted in OCT compound and 
frozen in dry-ice-cooled acetone. The tissue blocks for 
the in s i tu  hybridization were frozen rapidly in 
isopentane quenched with liquid nitrogen and 
subsequently freeze-substitution fixed in acetone 
containing formalin and then embedded in paraffin as 
previously described (Yamashita and Yasuda, 1992; 
Yamashita et al., 1996). Uteri collected from 6-7 animals 
were combined for each time point and processed for 
immunohistochemistry and in situ hybridization 
histochemistry. For Northern blot analysis, uteri from 6- 
8 mice were pooled, cut into small pieces and directly 
frozen in the liquid nitrogen and stored until isolation of 
RNA. 
lmmunohistochemistry 
Immunohistochemistry of ERs, and Fos and Jun has 
been previously reported ( respectively: Yamashita and 
Korach, 1989; Yamashita et al., 1996). Frozen sections, 
6-pm thick, were fixed with Zamboni's fixatives for 30 
minutes at room temperature. After incubation with 
0.2% glycine in phosphate-buffered saline (PBS), and 
successively with 10% normal goat serum and 1% 
bovine serum albumin in PBS, the sections were 
incubated with anti-Fos rabbit antibody (Oncogene 
Sciences Inc., MA) or anti-Jun rabbit antibody 
(Oncogene Sciences), each a 50-fold dilution with the 
blocking solution, or anti-ER monoclonal rat antibody 
(Abbott Laboratories, Abbott Park, IL) overnight at 4 "C. 
They were then treated with horseradish peroxidase- 
linked F(ab')2 fragments (Amersham Japan, Tokyo, 
Japan), 100-fold dilution, for 2 hours at room 
temperature. The peroxidase activity was detected with 
3,3'-diaminobenzidine solution containing nickel and 
cobalt ions (Adams, 1981). For controls, normal rabbit 
serum or antibodies absorbed with the respective 
peptides antigens were used as the primary antibodies; 
S-14-C or T-15-D (Oncogene Sciences) were incubated 
with anti-Fos or anti-Jun antibodies (Yamashita et al., 
1996). Normal rat IgG was used as the primary antibody 
for the control immunostaining of ER. 
In situ hybridization 
Cloning of murine cDNA fragments of c-fos and c- 
jun has been previously described (Yamashita et al., 
1996). The cDNA fragments of c-fos (195 bp) and c-jun 
(198 bp) were inserted at the Hinc 11 site of pSPT18 
(Boehringer Mannheim, Mannheim, Germany). 
Digoxigenin (Dig)-labeled RNA antisense and sense 
probes were prepared employing a Dig-RNA mixture 
(Boehringer Mannheim) and an AmpliScribe 
Transcription Kit (Epicebtre Technol., Badison, WI). 
Antisense probes of c-fos and c-jun were synthesized by 
T7 RNA polymerase using Hind 111-digested plasmids as 
templates, and sense probes were transcribed by SP6 
RNA polymerase using Xba 1-digested plasmids. 
We have previously reported the procedures of the in 
situ hybridization in detail (Yamashita et al., 1996). 
After deparaffinization, the sections were treated with 
0.2 N HCI, and with protease K (Sigma, P-2308), and 
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finally fixed with a 4% paraformaldehyde solution. The 
sections were incubated with Dig-labeled antisense or 
sense RNA probes at 45 "C overnight. After RNase A 
(Sigma, R-5250) treatment and washing, the sections 
were incubated with alkaline phosphatase-labeled anti- 
Dig Fab fragment (Boehringer Mannheim). The alkaline 
phosphatase enzyme activity was visualized with 5- 
bromo-4-chloro-3-indoxyl phosphate and nitroblue 
tetrazolium. 
Total RNA isolation 
Total RNA was isolated from the uterine horn. The 
frozen uteri were homogenized in 2.5 m1 of ice-cold 
RNAzol B (Tel-Test, Inc., Friendswood, TX) using a 
glass-teflon homogenizer. Total RNA was precipitated 
by addition of isopropanol, washed with 75% ethanol 
and finally dissolved in 1 mM EDTA. The concentration 
of total RNA was determined by measuring the optical 
density at 260 and 280 nm. 
Northern blof analysis 
Each sample, 5 p g  of total RNA in the buffer 
containing 45% formamide, 6% formaldehyde and 0.25 
mglml ethydium bromide, was separated on a 
formaldehyde -1% agarose gel and then transferred to 
nylon membrane by capillary blotting in 1 0  x SSC 
buffer. The blotted RNA was cross-linked under UV 
irradiation. The membrane was  incubated with 
prehybridization solution mixture and single strand DNA 
for 4 hours at 42 "C, then hybridized with 32~-labeled 
DNA probes overnight at 42 "C. After hybridization, the 
membranes were washed with 1% SDS in 2 x SSC twice 
for 30 minutes each at 65 "C and with 0.1% SDS in 0.1 x 
SSC twice for 30 minutes each at 65 "C, and they were 
then exposed to Bas 2000 imaging plates and scanned 
using a Bas 2000 image analyzer (Fuji Photo Film Co., 
Tokyo, Japan). 
The c-fos and c-jun inserts were PCR-ampliñed and 
32~-labeled by random priming using a Random Primer 
Extension Labeling System O\IEN Life Science Products 
Inc., Boston, MA) and [ 3 2 ~ ] - ~  (Arnersham Japan). 
Results 
Morphology 
In control 12-week-old mice that were 
ovariectomized at 10 weeks of age, the uterine luminal 
epithelia were lined with simple low-columnar 
epithelium, and glandular epithelia with the narrow 
uterine lumens were lined with cuboidal cells. In 12- 
week-old neonatally DES-exposed mice which were 
ovariectomized at 10 weeks of age (neoDES-mice), 
endometrial epithelium was composed of s imple 
columnar epithelium but pseudostratified columnar 
epithelium was also present in some regions. No 
squamous metaplasia was noted and the lumens of 
uterine glands were enlarged compared with those of 
vehicle-treated control mice (Fig. 4C-E). Apoptotic 
epithelial cells and clusters of epithelial cells being 
sloughed into the uterine lumens were observed more 
frequently in the neoDES-mice than in controls. Also, 
the myometrium was thin in the neonataily estrogenized 
mice. In particular, the inner circular layers were 
disordered showing sparse cell density (Fig. 5D), and 
uterine glands sometimes penetrated into the inner 
muscular layers. 
Localization of ERs 
ERs were localized in the nuclei of al1 major uterine 
cell-types, i.e., epithelial cells, stromal cells and 
muscular cells in the vehicle-treated control and 
neoDES-mice (Fig. 1). In the control mice uteri, 
glandular epithelium showed stronger ER-immuno- 
staining than luminal epithelium. In neonatally 
Flg. 1. lmmunohistochemistry of estrogen receptors (ERs) in the uteri of 
mice. ERs are localized in the uteri of 12-week-old control mouse (A) 
and neonatally diethylstilbestroi (DES)-exposed mouse (neoDES- 
mouse) (B), which were ovariectomized at 10 weeks of age. x 300 
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estrogenized mice, intensity of ER-immunostaining in 
the stromal and smooth muscle cells was almost the 
same as that in the controls, although uterine epithelial 
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cells seemed to show the same or slightly weaker 
reaction than those of control mice. 
Northern blot analysis of protooncogenes 
a) c-fos mRNA 
Total RNA was extracted from the uteri of control 
and neoDES-mice which were sacrificed either before (O 
hour, baseline) or at 1 ,  2, and 3 hours after E2 
administration. Al1 sample preparations showed single 
2.2 kb transcript on Northern blot analysis (Fig. 2A). 
Very low levels of c-fos mRNA were present in the 
uterine tissues of vehicle-treated control mice at 
baseline. A peak expression of c-fos mRNA, 15.8-fold 
relative to the baseline, was seen at 2 hours after E2 
injection, when the signals were analyzed on the basis of 
total RNA concentration (Fig. 2B). When the amount of 
c-fos transcripts was normalized on the basis of the B- 
actin mRNA level in the same blot, the peak of c-fos 
mRNA expression was at 1 hour after E2 injection; 11.2- 
fold more than the E2-unstimulated animals. In the uteri 
of neoDES-mice, the c-fos mRNA level was 2.2-fold 
higher than that of vehicle-treated control mice at 
baseline (Fig. 2B). E2 treatment also stimulated c-fos 
mRNA expression in neonatally estrogenized mice uteri, 
however, the inductive effect was low compared with 
controls. At 1 hour after E2 injection, the c-fos mRNA 
levels reached a peak showing a 2.1-fold increase 
compared with the value at baseline, even though total 
RNA or 8-actin mRNA concentrations were used for the 
normalization (Fig. 2B). The c-fos mRNA concentration 
was about 3-fold higher in the vehicle-treated control 
animals than in the neoDES-mice at 2 and 3 hours after 
E2 administration. 
b) c-jun mRNA 
Al1 specimens displayed 2.7 kb major bands and 3.2 
kb minor bands in Northern blotting (Fig. 2A); presence 
of these two forms of c-jun transcripts in rodents has 
been reported by many investigators (Persico et al., 
1990; Webb et al., 1993; Bigsbi and Li, 1994). Since it 
appeared that the ratio of the two bands was almost 
constant, we analyzed 2.7 kb major bands. The c-jun 
transcript levels in the uteri of vehicle-treated controls, 
rapidly increased showing a peak at 1 hour after E2 
treatment and returned to the baseline level at 3 hours; c- 
Flg. 2. Time course of c-fos, cjun and O-actin mRNA expression in the uteri 
of neonatally DES-exposed and unexposed control mice. The 12-week-old 
mice ovariectomized at the age of 10 weeks, are killed before (baseline) 
and 1 ,  2 and 3 hours after E2 injection and c-fos, cjun and B-actin mRNA 
levels are analyzed by Northern blot analysis of total RNA using s2P-labeled 
cDNAs, respectively. A. The mRNA signals in control mice (lanes 1-4) and 
neoDES-mice (lanes 5-8). Lanes 1 and 5, at baseline; lanes 2 and 6 , l  hour 
after E2 injection; lanes 3 and 7, 2 hours after E2 injection; lanes 4 and 8, 3 
hours after E2 injection. Quantitative analysis of c-fos (B) and c-jun (C) 
mRNA levels afler E2 injection. The mRNA concentrations are normalized 
on the basis of total RNA levels and B-actin mRNA levels, respectively. 
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jun mRNA peak level was 1.8-fold higher compared to 
the baseline value (Fig. 2C). When c-jun mRNA 
concentration was normalized with B-actin transcript 
levels, it was about 65% and 30% of the baseline value 
at 2 and 3 hours after E2 injection, respectively. The 
uterine c-jun mRNA level in the neoDES-mice was 70% 
of that in vehicle-treated control mice before E 2  
injection. E2 injection also elicited an increase in c-jun 
mRNA levels, although the increase was smaller than 
that of controls. At the 1 hour peak after E2 injection, c- 
jun mRNA concentration was 1.3-fold higher than 
compared with that at baseline, when it was normalized 
on the basis of total RNA or B-actin transcript levels. The 
concentration then decreased rapidly at 3 hours. 
Expression of c-fos protooncogene 
a) Immunohistochemistry 
In the control and neoDES-mice, single E2 injection 
induced c-fos protein in endometrial epithelium and 
vascular endothelium, but not in stromal and myometrial 
cells; however, the induction was weak in the neoDES- 
mice compared to controls. Before E2 injection, very 
faint immunoreaction was detectable in the nuclei of 
uterine epithelial cells in vehicle-trated controls (Fig. 
3A), and some epithelial cells showed a weak Fos- 
immunostaining in the neoDES-mice (Fig. 3C). The 
nuclear Fos-immunostaining gradually increased and 
peaked at 2 to 3 hours after E2 administration; Fos- 
immunoreaction was strong in the luminal epithelium 
and weak to moderate in the glandular epithelium (Fig. 
3B). In the uteri of neoDES mice, Fos-immunostaining 
in the luminal epithelium was slightly stronger than that 
in the glandular epithelium after 2 or 3 hours. The Fos- 
immuoreaction was heterogeneous among the epithelial 
cells (Fig. 3D), whereas it was almost homogeneous in 
the endometrial epithelium of control animals. No 
apparent differences in the Fos-immunostaining were 
observed between pseudostratified epithelium and 
simple columnar epithelium in the neoDES-mice uteri. 
In both neonatally vehicle treated-control and 
estrogenized-mice, vascular endothelium expressed Fos- 
immunoreaction in the nucleus at 2 hours after E2 
Flg. 3. lmmunohistochemistry of Fos in the uterus of mouse. Fos is localized in the uteri of control (A and B) and neoDES-mice (C and D). Animals 
saqr&@ b<~fore E2 injection (A and C) and 2 hours aíter injection (B and D). Arrows indicate Fos-immunoreaction in vascular endothelia. x 300 
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injection (Fig. 3B). 
b) In situ hybridization 
E2 treatment induced c-fos mRNA rapidly and 
transiently in the uterine epithelia and vascular 
endothelia of vehicle-treated control and neoDES-mice 
(Fig. 3). Expression of c-fos transcript was not evident in 
any of the uterine cell types of control mice before E2 
stimulation (Fig. 4A) but it reached a maximum in the 
epithelial cells at 2 hours (Fig. 4B) and in the endothelial 
cells at 1 hour after E2 injection, respectively. In the 
neoDES-mice at baseline, most uterine epithelia showed 
negative or very faint c-fos mRNA signals (Fig. 4C), 
while some epithelia displayed strong c-fos mRNA 
expression (Fig. 4D). Endometrial epithelium of 
neoDES-mice showed either the same or  slightly 
stronger c-fos mRNA signals a t  1 hour af ter  E2  
administration and weaker signals at 2 hours than those 
of vehicle-treated control animals. Glandular epithelium 
showed a weaker reaction than luminal epithelium in the 
uteri of both groups. Faint c-fos hybridization signals 
were present in the epithelium of both control and 
neoDES-mice 3 hours after E2 injection. 
Expression of c-jun protooncogene 
a) Immunohistochemistry 
E2 elicited differential c-jun expression responses in 
al1 uterine cell types: Jun-immunoreaction was localized 
in the nuclei of uterine cells (Fig. 5). There were no 
significant differences in the expression pattern of Jun 
between control and neoDES-mice. Epithelial cells 
displayed weak to moderate Jun-immunoreaction at 
baseline (Fig. 5A,C). The  intensity of Jun- 
immunostaining increased in the epithelial, stromal and 
myometrial cells from 2 to 3 hours after E2 treatment. 
Weak Jun-immunostaining was present in the endothelial 
cells of blood vessels at 2 hours. 
b) In situ hybridization 
Uteri of control and neoDES-mice provided almost 
the same c-jun mRNA expression pattern after E2 
administration. Strong c-jun mRNA signals were present 
Fig. 4. In situ localization of c-fos mRNAs in the mice uteri. Uteri of control (A and B) and neoDES mice (C-E). The c-fos mRNAs are detected in the 
uterine sections before E2 injection (A, C and D) and at 2 hours aiter E2 injection (B and E), by employing in situ hybridization histochemistry with 
digoxigenin (Dig)-labeled RNA probes. x 250 
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in the luminal epithelium and a weak reaction was seen 
in the glandular epithelium in the uteri of vehicle-treated 
control and neoDES-mice before E2 injection (Fig. 
6A,B). The amount of c-jun transcripts in the epithelial 
cells decreased at 1 , 2  and 3 hours after E2 treatment. No 
detectable c-jun mRNA was seen in the stromal or 
muscular cells at baseline and the mRNA was transiently 
induced and peaked at 1 to 2 hours after E2 injection 
(Figs. 6C,D). Vascular endothelium displayed c-jun 
mRNA signals at 1 hour. 
Discussion 
We investigated temporal and quantitative expression 
of c-fos and c-jun protooncogenes by E2 stimulation in 
the uteri of neoDES-mice. In Northern blot analysis, the 
c-fos mRNA concentration reached a peak at 2 hours 
after E2 injection in the uteri of vehicle-treated control 
mice, when the mRNA levels were compared with the 
total RNA concentration of each sample preparation 
(Fig. 2). However, c-fos mRNA expression peaked at 1 
hour in neoDES-mice, when normalized on the basis of 
the B-actin mRNA levels; a similar result was shown 
when compared with rat glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) mRNA levels (data not 
shown). Results of in situ hybridization revealed that the 
strongest c-fos mRNA signals were in the uterine 
epithelia at 2 hours after E2 administration. This finding 
agreed with our previous data obtained in adult mice, 
which were fed without neonatal DES-exposure and 
were ovariectomized at 12 week of age (Yamashita et al., 
1996). Postpubertal estrogen treatment also stimulated 
the expression of B-actin and GAPDH mRNAs in the 
mouse uterus. Therefore, the use of total mRNA levels 
seems to be reliable for the normalization of not only c- 
fos but also c-jun mRNA concentrations in the uteri of 
EZstimulated mice by the Northern blot analysis. 
The apoptotic epithelial cells and clusters of swollen 
epithelial cells being sloughed into the uterine lumens 
were obsewed more frequently in the uteri of neoDES- 
mice than in controls. Mori (1975) and Iguchi et al. 
(1985) reported that steady-state mitotic rates are higher 
in the uterine epithelia of ovariectomized adult mice that 
were exposed to DES neonatally than in those of 
vehicle-treated controls. These results indicate that the 
uterine epithelia of neonatally-estrogenized mice turn 
Flg. 5. Immunohistochemistry of Jun in control (A and B) and neoDES-mica (C and D). Localization of Jun is demonstrated in the uterine sections 
before (A and C) and 2 hours after E2 injection (B and D). m: myometrium. x 300. 
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over more rapidly compared with control animals even 
in the absence of estrogen stimulation. Hendry 111 et al. 
(1997) revealed that hyperplastic epithelium is also an 
active site of cell death by apoptosis in the uteri of 
neonatally DES-exposed and postpubertally estrogen- 
stimulated hamsters. The present data from Northern 
blot analysis revealed that the baseline level of c-fos 
mRNA was higher and c-jun mRNA was lower in the 
uteri of neoDES-mice than in those of vehicle-treated 
controls. Therefore, the persistent high c-fos and low c- 
jun mRNA levels might be responsible for the high- 
mitotic rates in the uterine epithelia of neonatally- 
estrogenized mice. 
Kamiya et al. (1996), employing Northern blot 
analysis, showed that the steady-state concentrations of 
both c-fos and c-jun mRNA were higher in the 
neonatally DES-exposed mice than in the vehicle-treated 
control animals. The reason for the inconsistency 
concerning the c-jun mRNA expression is unclear, and 
may result from the differences in the strain and age of 
mice. In the present study, nuclear Jun-immunostaining 
increased in the uterine epithelium of both control and 
neoDES-mice after E2 injection but c-jun mRNA levels 
decreased in these cells. The reason for the difference in 
the results by immunohistochemistry and in situ 
hybridization may be due to that accessibility of 
antibody to Jun in the nuclei became easy because of a 
change of nuclear structure after E2 injection, or that 
translation of c-jun mRNA may be activated in the E2- 
stimulated epithelial cells. 
The c-fos gene expression appeared heterogeneous 
in the uterine epithelium of neoDES-mice. The c-fos 
mRNA and protein were synthesized more rapidly in 
some populations of the uterine epithelia in the neoDES- 
mice than in the vehicle-treated controls.  Some 
epithelium showed strong and others exhibited faint 
immunostaining and in situ hybridization signals at 2 
hours after E2 injection, while the epithelium of control 
animals showed almost homogeneous c-fos expression 
(Figs. 3, 4). In addition, few epithelial cells displayed 
high c-fos mRNA expression in the uteri of neonatally- 
estrogenized mice without E2 injection (Fig. 4D). These 
results suggest that the uterine epithelia of neonatally 
DES-treated mice are composed of a heterogeneous 
Fig. 6. In situ localization of c-jun rnñNAs in the rnice uteri in conrroi (A and B) and neoDES-mice (C and D). Expression of c-jun rnRNAs is seen in the 
uteri before (A and C) and 2 hours aíter E2 injection (B and D), by ernploying in situ hybridization with Dig-labeled RNA probes. m: rnyornetriurn. x 250 
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population in relation to their responses to postpubertal 
estrogen stimulation. Mori (1975) pointed out that 
uterine epithelia of ovariectomized neonatally DES- 
exposed mice consisted of a mixed population of cells; 
total mitotic rate of uterine epithelia in the neonatally 
DES-exposed mice was about 30% of that for control 
mice after a single injection of E2, but the epithelia 
rapidly entered the mitotic stage. 
Nelson et al. (1994) demonstrated that neonatal DES 
exposure results in the persistent ovary-independent 
activation of estrogen-regulated genes, such a s  
lactoferrin and EGF genes in the mouse uterus and 
vagina. Iguchi et al. (1993) showed that EGF receptor 
levels in neonatally DES-treated mice were almost the 
same in the uterus and oviduct but significantly lower in 
the vagina compared with those of control animals. The 
present study also revealed that the baseline levels of 
estrogen-regulated protooncogenes alter in the uteri of 
neoDES-mice. One of the mechanisms of alteration of 
estrogen-regulated gene expression may be based on the 
demethylation or methylation of DNA in the genital tract 
of neonatally-estrogenized mice. Li et al. (1997) 
reported that neonatal DES-treatment imprinted an 
abnormal, site-specific demethylation of immediately 
upstream from the estrogen responsive element of 
lactoferrin promoter, and that the demethylation was 
maintained in uterine tumors developed from neonatally 
DES-treated mice. In addition, persistent EGF 
expression in the uterus of neonatally DES-exposed mice 
may lead to the ovary-independent expression of c-fos 
transcripts, because the c-fos mRNA expression is shown 
to be stimulated through the EGF signaling pathway 
system independently of ER systems in the mouse uterus 
(Curtis et al., 1996). 
The low sensitivity of c-fos expression to E2 
administration in the uterine epithelia of neoDES-mice 
may not be simply proportional to the concentration of 
ERs, because there were no significant differences in ER 
expression pattern between neoDES-mice and controls 
(Fig. 1). Sato et al. (1992) showed almost the same ER- 
immunostaining pattern in the uteri of neonatally 
vehicle-treated control and DES-exposed mice. 
Neonatal DES exposure elicited alterations in 
expression patterns of estrogen-regulated nuclear 
protooncogens, c-fos and c-;un, in the mice uteri; the c- 
fos mRNA expression at baseline was higher and that of 
c-;un was lower in the uteri of neoDES-mice compared 
with vehicle-treated control animals. Almost the same 
results were observed in the uteri of 3-week-old 
neoDES-mice (Yamashita S, Takayanagi A, Shimizu N, 
unpublished data). In the male reproductive tissues, Salo 
et al. (1997) demonstrated that neonatal DES treatment 
results in a increase of c-fos mRNA expression in the 
epithelial cells of prostatic urethra and al1 prostatic lobes 
compared with non-treated control mice at of 3-5 months 
of age. In situ hybridization and immunohistochemistry 
displayed that c-fos is expressed primarily in the 
epithelium of posterior periurethral prostatic collecting 
ducts, which are sites that show the most pronounced 
morphological changes in neoDES-mice. Long-term 
expression of Fos was shown to cause loss of epithelial 
polarity irreversibly and trigger epithelial-fibroblastoid 
cell conversion (Reichmann et al., 1992). A function of 
Jun in the epithelium appears to modulate epithelial 
polarity and tissue organization; expression of Jun elicits 
a loss of mammary epithelial polarity involving a 
destabilization of adherens junctions (Fialka et al., 
1996). The persistent changes in the expression of 
estrogen-regulated genes such as c-fos, c-;un and EGF 
which regulate the cell differentiation and proliferation, 
should be responsible for the wide ranges of 
abnormalities in the genital tract of perinatally- 
estrogenized animals. 
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